LifeMD, Inc. (LFMD) Tops Q1 EPS by 14c ; Offers Guidance

LifeMD, Inc. (NASDAQ: LFMD) reported Q1 EPS of $0.01, $0.14 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $44.14 million versus the consensus estimate of $42.54 million.

GUIDANCE:

LifeMD, Inc. sees Q2 2024 revenue of $48-50 million, versus the consensus of $47.15 million.

LifeMD, Inc. sees FY2024 revenue of ~$205 million, versus the consensus of $201.3 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance